Veltek Associates, Inc. - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Veltek Associates, Inc. (VAI) provides innovative solutions to address the control of particulate and microbial contamination in pharmaceutical and biotechnology operations worldwide.  We focus on the identification and control of contamination in classified areas.

VAI’s Sterile Chemical Manufacturing Division (SCMD) produces a complete range of sterile disinfectants, sanitizers, sporicides, lubricants, cleaners, detergents (CIP), and buffer solutions.  We offer hand sanitizers and hands-free dispensing systems in addition to developing the Core2Clean Plus System that can spray, mop or fog in one device.   

VAI’s Environmental Control Monitoring Division (ECMD) designs an assortment of viable air sampling equipment.  This product line includes portable devices, compressed air sampling, and facility wide monitoring systems with numerous possibilities to maximize the use of EM information.

VAI’s Disposable Products Manufacturing Division (DPMD) offers sterile cleanroom garments, face masks and nylon packaging material.  These garments also come in a patented fold (Easy2Gown) that makes gowning simple and easy for your operators.



VAI Labs provides microbiological testing ranging from the identification of microorganisms to antimicrobial effectiveness studies, a disinfectant validation service. 

Aseptic Processing Inc. (consulting) provides consulting services in aseptic technique, environmental monitoring, component entry systems, personnel gowning, cleaning and disinfecting systems, and media fill trials.

Veltek Associates, Inc.
www.sterile.com
vai@sterile.com

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerRelationship-building at Top of Mind for Clients
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerRisk Reduction Top Driver for Biopharmaceutical Raw Material Development
Jill Wechsler Regulatory Watch Jill Wechsler Changes and Challenges for Generic Drugs
Faiz Kermaini Industry Insider Faiz KermainiNo Signs of a Slowdown in Mergers
CMOs and the Track-and-Trace Race: Are You Engaged Yet?
Ebola Outbreak Raises Ethical Issues
Better Comms Means a Fitter Future for Pharma, Part 2: Realizing the Benefits of Unified Communications
Better Comms Means a Fitter Future for Pharma, Part 1: Challenges and Changes
Sandoz Wins Biosimilar Filing Race
FindPharma Custom Search

Click here